WearOptimo Blog

Mark Kendall’s career was meant to reach Mars—literally.

WearOptimo Media Release

Share this page on socials

Mark Kendall’s career was meant to reach Mars—literally.

In his PhD, he fired microparticles through a Mach-42 wind tunnel to model planetary re-entry. Then an Oxford mentor asked:
“Could you turn that rocket physics into a way to deliver vaccines through skin?”

Mark said yes, swapped aerospace for biomedicine, and has spent two decades proving that millimetres > megawatts when it comes to human health.

His latest venture, WearOptimo, uses hair-width micro-electrodes that sit one skin-layer deep, exactly where hydration shifts first. And an on-device AI converts those signals into live read-outs.

Why hydration?

– 70 % of miners start a shift dehydrated; heat stress kills hundreds yearly.
– About 40 % of soldiers in Australian field exercises show dehydration-linked heat illness.
– Elite athletes deliberately “run dry” by 7-10 % chasing marginal gains, costing power, cognition, and increasing concussion risk.

Kendall holds more than 160 patents, earlier founded Vaxxas to commercialise his Nanopatch vaccine platform, and remains driven by a simple goal: “Use the skin not just to listen to the body but to save it.”

Mark was recently selected to join the Unreasonable Impact Asia Pacific 2025 programme, a collaboration between Unreasonable and Barclays dedicated to scaling businesses that merge profit and impact.

Through this programme, WearOptimo will gain access to world-class mentorship, resources, and a powerful global network to accelerate its growth and maximise its impact.
Read More >

Keep Reading